Open company graph database — free web & API
Login

Chordia Therapeutics Inc.

Chordia Therapeutics株式会社
Ticker
Listed market
TYO
Country
Japan
Employees (non-consolidated)
22
Related companies
12
§01

Basic information

BASIC
Head office
Kanagawa Prefecture, Fujisawa City, Muraoka Higashi 2-chome, 26-1
Chief executive
Hiroshi Miyake
Capital
845,000,000 JPY (8 100 millionJPY)
Employees (non-consolidated)
22 people
Employees (consolidated)
Start date
2017-10-12
End date
§02

Websites

1 DOMAINS
§03

Business

3
Development of pharmaceutical drugsClinical testing servicesLicensing of drug candidates
§04

Related companies

12 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Medipal Holdings Corporation
Group Customer
Chijuu Pharmaceutical Co., Ltd.
Group Customer
De Western Therapeutics Research Institute Inc.
Group Customer
Shionogi Pharma Co., Ltd.
Group Customer
ONO PHARMACEUTICAL CO., LTD.
Group Customer
ZUU Wealth Management Co., Ltd.
Customer
Advisor Navi Inc.
Customer
General Incorporated Association Life Science Innovation Network Japan
Customer
Sogyo Tech Corporation
Customer
SBI SECURITIES Co.,Ltd.
Customer
Stock Voice Inc.
Customer
Fisco Inc.
Customer
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

12 EVENTS

Establishment of Chordia Therapeutics Inc.Sources

Establishment of Chordia Therapeutics Inc.Sources

Fundraising of approximately 1.2 billion yen in Series A roundSources

Start of Phase 1 trial in Japan for RogocekibSources

Fundraising of approximately 3 billion yen in Series B roundSources

Acquisition of exclusive worldwide rights for 4 programs from Takeda Pharmaceutical CompanySources

License-out of MALT1 inhibitor drug with Ono Pharmaceutical (rights returned on April 28, 2025)Sources

Fundraising of approximately 4 billion yen in Series C roundSources

Initiation of Phase 1/2 trials in the United StatesSources

Listed on the Tokyo Stock Exchange Growth MarketSources

Okaya University appointed Mr. Yoichi Oka as CFO, currently serving. After working in audit at a major auditing firm, he has led M&A advisory services and supervised organizations as head of corporate management departments, leading the formulation and execution of financial strategies.Sources

Mr. Yoshiyuki Tanaka was appointed Chief Medical Officer (CMO) of Chordia Therapeutics Inc. in January 2026, currently serving.Sources

§07

News

0 ARTICLES

There is no news.

§08

Public records

GOV
National Tax Agency basic information1021001063330
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
Chordia Therapeutics株式会社
Trade name (kana)
コーディアセラピューティクス
Name in English
Corporation type
301
Address
〒251-0012 神奈川県藤沢市村岡東2丁目26番地の1
Postal code
2510012
Prefecture code
14
City code
205
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2017-10-19
Update date
2023-06-02
Change date
2017-10-19
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
01
Correction type
1
Trade name image ID
Address image ID
Sequence number
2638876
METI gBizINFO1021001063330
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
1021001063330
Trade name
Chordia Therapeutics株式会社
Trade name (kana)
コーディアセラピューティクス
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
神奈川県藤沢市村岡東2丁目26番地の1
Postal code
2510012
Prefecture
神奈川県
Prefecture code
14
City or district
藤沢市
City code
205
Street address
村岡東2丁目26番地の1
Organisation type
301
Processing type
01
Correction type
1
Status
Representative
代表取締役 三宅 洋
Capital
876270000
Employees
20
Employees (male)
Employees (female)
Business summary
Website URL
Year founded
Business category
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2023-06-02
Key information
1021001063330
§09

Sources & updates

SOURCES
↑